Baicalin reduces anorexia by inhibiting cytokine expression (TNF-α and IL-6), prevents muscular atrophy by reducing MuRF1 and atrogin-1 expression, and inhibits NF-κB activation in a cancer cachexia model [233]. This evidence concerns the gene FBXO32 and cancer.